BRIEF-Akili and Pfizer present positive data from digital biomarker study

* No safety concerns were reported during digital biomarker study
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.